ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 255,86
0,29%
Dow Jones
44 910,65
0,00%
DAX
19 889,88
1,33%
Brent Oil
72,745
0,93%
Bitcoin
95 734,32
-1,57%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sigilon Therapeutics Inc (SGTX)

  7. Sigilon Therapeutics Inc (SGTX) Actualités

SGTX

Sigilon Therapeutics (SGTX)

Sigilon Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SGTX
DateHeureSourceTitreSymboleSociété
21/08/202314h22Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:SGTXSigilon Therapeutics Inc
16/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SGTXSigilon Therapeutics Inc
14/08/202313h25PR Newswire (US)Lilly Completes Acquisition of Sigilon TherapeuticsNASDAQ:SGTXSigilon Therapeutics Inc
11/08/202322h28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGTXSigilon Therapeutics Inc
11/08/202322h20Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SGTXSigilon Therapeutics Inc
11/08/202322h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGTXSigilon Therapeutics Inc
11/08/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGTXSigilon Therapeutics Inc
10/08/202314h31Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:SGTXSigilon Therapeutics Inc
07/08/202314h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SGTXSigilon Therapeutics Inc
13/07/202314h18Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SGTXSigilon Therapeutics Inc
29/06/202313h35Dow Jones NewsEli Lilly to Acquire Sigilon TherapeuticsNASDAQ:SGTXSigilon Therapeutics Inc
29/06/202313h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SGTXSigilon Therapeutics Inc
29/06/202312h57Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:SGTXSigilon Therapeutics Inc
29/06/202312h45PR Newswire (US)Lilly to Acquire Sigilon TherapeuticsNASDAQ:SGTXSigilon Therapeutics Inc
22/05/202322h21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGTXSigilon Therapeutics Inc
22/05/202313h30GlobeNewswire Inc.Sigilon Announces Reverse Stock Split of Common StockNASDAQ:SGTXSigilon Therapeutics Inc
09/05/202314h11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SGTXSigilon Therapeutics Inc
09/05/202313h30GlobeNewswire Inc.Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
02/05/202315h00PR Newswire (US)Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior AdvisorNASDAQ:SGTXSigilon Therapeutics Inc
18/04/202313h00GlobeNewswire Inc.Sigilon Therapeutics to Present at the Needham Virtual Healthcare ConferenceNASDAQ:SGTXSigilon Therapeutics Inc
06/04/202313h07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SGTXSigilon Therapeutics Inc
06/04/202313h03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SGTXSigilon Therapeutics Inc
23/03/202322h01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SGTXSigilon Therapeutics Inc
14/03/202321h26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SGTXSigilon Therapeutics Inc
14/03/202321h15GlobeNewswire Inc.Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
01/03/202322h37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SGTXSigilon Therapeutics Inc
10/11/202213h30GlobeNewswire Inc.Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
04/08/202222h30GlobeNewswire Inc.Sigilon Therapeutics Reports Second Quarter 2022 Financial Results and Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
08/07/202222h58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SGTXSigilon Therapeutics Inc
12/05/202222h05GlobeNewswire Inc.Sigilon Therapeutics Reports First Quarter 2022 Financial Results And Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SGTX

Dernières Valeurs Consultées

SPI
SP500
S&P 500
EU
VK
Vallourec
NASDAQ
AAPL
Apple
EU
BNP
BNP Paribas
COIN
AVAXUSD
Avalanche
NYSE
MCD
McDonalds
EU
ACA
Credit Agricole
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
EU
BEL20
Bel 20
EU
PX1
CAC 40
EU
PX4
SBF 120
COIN
XRPUSD
Ripple
NYSE
NKE
Nike
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

BLACK FRIDAY

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct